Chemo Pharma Laboratories (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Chemo Pharma Laboratories Limited |
|||
|
Price: ₹107.60 | ||
| 52 Week Low: ₹52.25 52 Week High: ₹154.00 |
|||
| Market Capital: 12.3 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Chemo Pharma Laboratories Share Price Target For 2024
- 1.1.1: Chemo Pharma Laboratories Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Chemo Pharma Laboratories Share Price Target For 2025
- 1.2.1: Chemo Pharma Laboratories Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Chemo Pharma Laboratories Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Chemo Pharma Laboratories Financial Performance
- 3.0.1: Is Chemo Pharma Laboratories A Good Buy For Long Term?
To predict the Chemo Pharma Laboratories's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Chemo Pharma Laboratories Share Price Target For 2024
The line chart displays the monthly closing prices of Chemo Pharma Laboratories with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Chemo Pharma Laboratories shares in 2024, see the table below.
Chemo Pharma Laboratories Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 122.47 (+13.81%) | Price Action: Chart |
| 2024 Target 2 | 120.19 (+11.7%) | Price Action: Chart |
| 2024 Target 1 | 119.0 (+10.59%) | Price Action: 16 Dec 2024 High |
| Current Price | 107.60 | Chemo Pharma Laboratories's share price as of 26 Dec 2024 |
| Stop Loss 1 | 100.19 (-6.89%) | Fibonacci Retracement Level 71.80% |
| Stop Loss 2 | 98.21 (-8.73%) | Price Action: 23 Dec 2024 High |
| Stop Loss 3 | 97.0 (-9.86%) | Price Action: 06 Dec 2024 High |
Short-Term Technical Outlook
Current Technical Position: Chemo Pharma Laboratories is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹98.58 serves as the nearest technical reference point.
Historical Returns: 3-month: +55.72% | 6-month: +63.03% | 1-year: +65.08%
Chemo Pharma Laboratories Share Price Target For 2025
The line chart displays the monthly closing prices of Chemo Pharma Laboratories with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Chemo Pharma Laboratories shares in 2025, see the table below.
Chemo Pharma Laboratories Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 186.09 (+72.94%) | Price Action: Chart |
| 2025 Target 2 | 182.62 (+69.72%) | Price Action: Chart |
| 2025 Target 1 | 180.81 (+68.03%) | Fibonacci Extension Level 123.60% |
| Current Price | 107.60 | Chemo Pharma Laboratories's share price as of 26 Dec 2024 |
| Stop Loss 1 | 90.0 (-16.36%) | Price Action: 23 Dec 2024 Low |
| Stop Loss 2 | 88.9 (-17.38%) | Price Action: 18 Nov 2024 High |
| Stop Loss 3 | 87.99 (-18.23%) | Price Action: 04 Nov 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Chemo Pharma Laboratories is currently trading at 54.4% of its 52-week range (₹52.25 - ₹154).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +65.08% | 3-year: +228.05% | 5-year: +1,452.67%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Chemo Pharma Laboratories Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹107.60 | ||
| 2024 | ₹85.15 | -20.86% | ₹86.43 |
| 2025 | ₹82.85 | -2.7% | ₹84.09 |
| 2026 | ₹85.28 | +2.93% | ₹91.01 |
| 2027 | ₹80.17 | -5.99% | ₹96.75 |
| 2028 | ₹90.77 | +13.22% | ₹99.48 |
| 2029 | ₹107.98 | +18.96% | ₹109.60 |
| 2030 | ₹103.94 | -3.74% | ₹105.50 |
| 2031 | ₹105.94 | +1.92% | ₹107.53 |
| 2032 | ₹98.69 | -6.84% | ₹100.17 |
| 2033 | ₹110.81 | +12.28% | ₹112.47 |
| 2034 | ₹130.82 | +18.05% | ₹132.78 |
| 2035 | ₹125.03 | -4.42% | ₹126.91 |
| 2036 | ₹126.59 | +1.24% | ₹136.94 |
| 2037 | ₹117.21 | -7.4% | ₹142.69 |
| 2038 | ₹130.85 | +11.63% | ₹148.43 |
| 2039 | ₹154.17 | +17.82% | ₹156.48 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Chemo Pharma Laboratories Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 12.3 Crore | Market valuation of Chemo Pharma Laboratories's shares. |
| Net Income (TTM) | +1.2 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Is Chemo Pharma Laboratories A Good Buy For Long Term?
Chemo Pharma Laboratories, a small-cap stock with a market capitalization of 12.3 crore, presents a mixed long-term investment picture. While its past performance is impressive, boasting 93.54% returns over the past year and a remarkable 212.31% increase over three years, recent performance shows some volatility. The 6-month return of -2.22% warrants caution. Given the inherent risk associated with small-cap stocks and the recent dip, it's currently rated as an average buy for long-term investors with a high-risk tolerance. Further due diligence is strongly recommended.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
